Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31

Trial Status

Other3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT05956626Phase 2/3Active Not Recruiting
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Stargardt Disease
StudychairStart date: 2023-08-25
NCT06018558Phase 1/2Active Not Recruiting
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
Geographic Atrophy
StudychairStart date: 2023-02-23
Expanded Access Program for RP in Adults
Retinitis Pigmentosa
Studychair

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Ocugen., Inc

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05956626Phase 2/3StudyChair

A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

Stargardt Disease
Active Not Recruiting
NCT06018558Phase 1/2StudyChair

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

Geographic Atrophy
Active Not Recruiting
NCT06574997StudyChair

Expanded Access Program for RP in Adults

Retinitis Pigmentosa
Unknown

All 3 trials loaded